BACK TO NEWS

UPDATES FROM MERCK II: GOLD SPONSOR OF THE CHT2023 CONFERENCE

Thursday 9 November 2023

We are delighted to share an update from our CHT2023 Gold Sponsor, Merck, below.

Merck Healthcare KGaA’s Growzen™: Nurturing Hope for Pediatric Growth Hormone Disorders

Pediatric growth hormone disorders, caused by deficiencies or abnormalities in growth hormone production, have long posed medical challenges. Merck Healthcare KGaA has developed the innovative digital health ecosystem, Growzen™, to provide comprehensive support for pediatric patients, caregivers, and healthcare professionals dealing with these conditions.

Growzen™ comprises the Growzen™ Buddy app, a digital companion for pediatric patients. It offers support, education, and engagement in a relatable and interactive manner. Through this app, children can access resources, track their progress, and connect with patient support services. It empowers them to take an active role in their treatment, fostering a sense of control and resilience.

Caregivers also benefit from Growzen™ Buddy app, gaining access to vital information and resources that enhance their ability to provide optimal care and support. This equips parents and caregivers with the knowledge and tools necessary to navigate the complex landscape of growth hormone disorders, making them active partners in the treatment journey.1

Healthcare professionals find value in Growzen™ as well. The Growzen™ Connect web-based platform provides real-time insights into patient progress and experiences, enabling more personalized and effective care.1 Healthcare providers can monitor treatment outcomes, adjust therapies as needed, and collaborate seamlessly with patients and caregivers. 1 This data-driven approach enhances the quality of care and ensures the best possible outcomes for pediatric patients.

Merck Healthcare KGaA’s Growzen™ is transforming the approach to pediatric growth hormone disorders by offering innovative solutions that nurture hope and empowerment. This holistic approach represents a significant advancement in pediatric healthcare, promising a brighter future for countless young lives.

Reference

  1. Tornincasa V, Dixon D, Le Masne Q, Martin B, Arnaud L, van Dommelen P, Koledova E. Integrated digital health solutions in the management of growth disorders in pediatric patients receiving growth hormone therapy: a retrospective analysis. Frontiers in Endocrinology. 2022 Jun 30;13:882192.

GL-SAI-00192
November 2023